Suppr超能文献

CD81细胞表面表达水平是丙型肝炎病毒有效进入宿主细胞的关键决定因素。

The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

作者信息

Koutsoudakis George, Herrmann Eva, Kallis Stephanie, Bartenschlager Ralf, Pietschmann Thomas

机构信息

Department Molecular Virology, University Heidelberg, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany.

出版信息

J Virol. 2007 Jan;81(2):588-98. doi: 10.1128/JVI.01534-06. Epub 2006 Nov 1.

Abstract

Recently a cell culture model supporting the complete life cycle of the hepatitis C virus (HCV) was developed. Searching for host cell determinants involved in the HCV replication cycle, we evaluated the efficiency of virus propagation in different Huh-7-derived cell clones. We found that Huh-7.5 cells and Huh7-Lunet cells, two former replicon cell clones that had been generated by removal of an HCV replicon by inhibitor treatment, supported comparable levels of RNA replication and particle production, whereas virus spread was severely impaired in the latter cells. Analysis of cell surface expression of CD81 and scavenger receptor class B type I (SR-BI), two molecules previously implicated in HCV entry, revealed similar expression levels for SR-BI, while CD81 surface expression was much higher on Huh-7.5 cells than on Huh7-Lunet cells. Ectopic expression of CD81 in Huh7-Lunet cells conferred permissiveness for HCV infection to a level comparable to that for Huh-7.5 cells. Modulation of CD81 cell surface density in Huh-7.5 cells by RNA interference indicated that a certain amount of this molecule (approximately 7 x 10(4) molecules per cell) is required for productive infection with a low dose of HCV. Consistent with this, we show that susceptibility to HCV infection depends on a critical quantity of CD81 molecules. While infection is restricted in cells expressing very small amounts of CD81, susceptibility rapidly rises within a narrow range of CD81 levels, reaching a plateau where higher expression does not further increase the efficiency of infection. Together these data indicate that a high density of cell surface-exposed CD81 is a key determinant for productive HCV entry into host cells.

摘要

最近开发了一种支持丙型肝炎病毒(HCV)完整生命周期的细胞培养模型。为了寻找参与HCV复制周期的宿主细胞决定因素,我们评估了病毒在不同源自Huh-7的细胞克隆中的传播效率。我们发现,Huh-7.5细胞和Huh7-Lunet细胞这两个先前通过抑制剂处理去除HCV复制子而产生的复制子细胞克隆,支持相当水平的RNA复制和病毒颗粒产生,而病毒在后者细胞中的传播严重受损。对CD81和B类I型清道夫受体(SR-BI)这两种先前与HCV进入有关的分子的细胞表面表达分析显示,SR-BI的表达水平相似,而CD81在Huh-7.5细胞上的表面表达远高于Huh7-Lunet细胞。在Huh7-Lunet细胞中异位表达CD81赋予了对HCV感染的易感性,其水平与Huh-7.5细胞相当。通过RNA干扰调节Huh-7.5细胞中CD81的细胞表面密度表明,低剂量HCV有效感染需要一定量的该分子(约每细胞7×10⁴个分子)。与此一致,我们表明对HCV感染的易感性取决于CD81分子的临界数量。虽然在表达极少量CD81的细胞中感染受到限制,但在CD81水平的狭窄范围内易感性迅速上升,达到一个平台期,更高的表达不会进一步提高感染效率。这些数据共同表明,细胞表面暴露的高密度CD81是HCV有效进入宿主细胞的关键决定因素。

相似文献

3
4
CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
J Virol. 2004 Feb;78(3):1448-55. doi: 10.1128/jvi.78.3.1448-1455.2004.
6
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
J Biol Chem. 2003 Oct 24;278(43):41624-30. doi: 10.1074/jbc.M305289200. Epub 2003 Aug 11.
8
Active RNA replication of hepatitis C virus downregulates CD81 expression.
PLoS One. 2013;8(1):e54866. doi: 10.1371/journal.pone.0054866. Epub 2013 Jan 22.

引用本文的文献

1
Genetic and transcriptional insights reveal hepatitis C virus as a driver of kidney cancer.
Infect Agent Cancer. 2025 Sep 2;20(1):63. doi: 10.1186/s13027-025-00693-9.
2
Hepatitis C virus NS3 helicase contributes to (-) strand RNA synthesis.
Nat Commun. 2025 Aug 27;16(1):8006. doi: 10.1038/s41467-025-63498-9.
3
Yaravirus brasiliense genomic structure analysis and its possible influence on the metabolism.
Genet Mol Biol. 2025 Feb 7;48(1):e20240139. doi: 10.1590/1678-4685-GMB-2024-0139. eCollection 2025.
5
Human tetraspanin CD81 facilitates invasion of into human epithelial cells.
Virulence. 2024 Dec;15(1):2399792. doi: 10.1080/21505594.2024.2399792. Epub 2024 Sep 24.
7
The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity.
PLoS Pathog. 2023 Nov 15;19(11):e1011759. doi: 10.1371/journal.ppat.1011759. eCollection 2023 Nov.
8
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies.
PLoS Comput Biol. 2023 Apr 4;19(4):e1010423. doi: 10.1371/journal.pcbi.1010423. eCollection 2023 Apr.
10
Hepatitis Virus C-associated Nephropathy: A Review and Update.
Cureus. 2022 Jul 27;14(7):e27322. doi: 10.7759/cureus.27322. eCollection 2022 Jul.

本文引用的文献

2
Hepatitis C virus entry depends on clathrin-mediated endocytosis.
J Virol. 2006 Jul;80(14):6964-72. doi: 10.1128/JVI.00024-06.
4
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7408-13. doi: 10.1073/pnas.0504877103. Epub 2006 May 1.
5
Hepatitis C virus entry: potential receptors and their biological functions.
J Gen Virol. 2006 May;87(Pt 5):1075-1084. doi: 10.1099/vir.0.81646-0.
6
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):6001-6. doi: 10.1073/pnas.0601523103. Epub 2006 Apr 3.
7
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3805-9. doi: 10.1073/pnas.0511218103. Epub 2006 Feb 16.
8
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2310-5. doi: 10.1073/pnas.0510727103. Epub 2006 Feb 6.
9
Cell entry of hepatitis C virus.
Virology. 2006 Apr 25;348(1):1-12. doi: 10.1016/j.virol.2005.12.027. Epub 2006 Feb 7.
10
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.
J Virol. 2006 Feb;80(4):1734-41. doi: 10.1128/JVI.80.4.1734-1741.2006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验